Rockefeller Capital Management
NMTR

Rockefeller Capital Management’s 9 Meters Biopharma NMTR Stock Holding History

Rockefeller Capital Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000
Closed -$1K – 4147
2022
Q4 		$1K Hold
1,000
– – ﹤0.01% 3799
2022
Q3 		$4K Buy
+1,000
New +$4.96K ﹤0.01% 3445
2020
Q4 		– Sell
-5
Closed – – 3055
2020
Q3 		$0 Buy
+5
New +$61 ﹤0.01% 2869

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rockefeller Capital Management's NMTR Position: Q1 2023 in Review

Rockefeller Capital Management sold out of 9 Meters Biopharma (NMTR) in Q1 2023, closing a stake of 1,000 shares — an estimated $1K sold.

Rockefeller Capital Management first reported a position in NMTR in Q3 2020 and held it in 3 quarters. The position peaked at $4K in Q3 2022. 39 funds tracked by Wall St. Rank hold NMTR as of Q1 2023.

  • Rockefeller Capital Management reported no remaining 9 Meters Biopharma position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 1,000 9 Meters Biopharma shares in Q1 2023, an estimated $1K.
  • Rockefeller Capital Management first reported a position in 9 Meters Biopharma in Q3 2020 and held it in 3 quarters.
  • Rockefeller Capital Management's 9 Meters Biopharma position peaked at $4K in Q3 2022.
  • 39 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.